# Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac Disease

> **NCT03486990** · PHASE1 · COMPLETED · sponsor: **Takeda** · enrollment: 23 (actual)

## Conditions studied

- Celiac Disease

## Interventions

- **DRUG:** TIMP-GLIA

## Key facts

- **NCT ID:** NCT03486990
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-23
- **Primary completion:** 2019-05-24
- **Final completion:** 2019-07-22
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2020-06-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03486990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03486990, "Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac Disease". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03486990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*